Apotex Health Corp. (APTX.TO)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in CADTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CAD m | - | - | - | 2,940 | 3,350 | 3,491 | - | 3,491 |
| Operating profit | CAD m | 786 | - | ||||||
| Net profit | CAD m | - | - | - | -147 | 152 | 374 | - | 446 |
| EPS reported | CAD | 1.61 | - | ||||||
| Operating cashflow per share | CAD | 2.77 | - | ||||||
| Capex per share | CAD | 0.79 | - | ||||||
| FCF per share | CAD | 1.98 | - | ||||||
| Free cash flow | CAD m | 459 | - | ||||||
| Net debt | CAD m | 2,883 | - | ||||||
| Book value equity | CAD m | -558 | - | ||||||
| Book value per share | CAD | -2.41 | - | ||||||
| Number of shares | m | 231.73 | - | ||||||
| DPS (TTM paid) | CAD | 4.79 | - |
Financial summary
Financials in CADTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | -11.06 | - | ||||||
| P/S LTM | x | 1.77 | - | ||||||
| P/FCF LTM | x | 13.44 | - | ||||||
| EV/EBITDA LTM | x | 9.59 | - | ||||||
| EV/Sales LTM | x | 2.78 | - | ||||||
| Earnings Yield LTM | % | +5.97% | - | ||||||
| FCF Yield | % | +7.44% | - | ||||||
| Quality | |||||||||
| ROE | % | -66.99% | - | ||||||
| ROIC | % | +17.62% | - | ||||||
| Operating margin | % | +22.52% | - | ||||||
| Gross margin | % | +55.62% | - | ||||||
| FCF/Sales | % | +13.15% | - | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +143.94% | - | ||||||
| Sales Growth YoY | % | +4.21% | - | ||||||
| Net Income Growth YoY | % | +146.39% | - | ||||||
| FCF Growth | % | +47.90% | - | ||||||
| Operating Profit Growth | % | +42.31% | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +17.74% | - | ||||||
| Dividend Growth | % | +567.37% | - | ||||||
| Payout Ratio | % | +297.42% | - | ||||||
| FCF/Debt | x | 0.13 | - | ||||||
| Net Debt/EBITDA | x | 3.80 | - | ||||||
| EBIT/Net interest | x | 3.24 | - | ||||||
| Net debt/market cap | % | +46.99% | - | ||||||
| Net debt/Equity | x | -5.17 | - | ||||||
| Gross debt/equity | x | -6.31 | - | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India. The company develops, manufactures, and distributes a broad portfolio of prescription and generic pharmaceuticals, oncology biosimilar pharmaceuticals, branded specialty pharmaceuticals, and branded consumer health and wellness products. It operates through three business lines including conventional generic pharmaceuticals; specialty generic pharmaceuticals; and brands & biosimilars. The company has a a strategic partnership with Halo Pharmaceutical, Inc. The company was formerly known as Artemis Parent, Inc. and changed its name to Apotex Health Corp. in May 2026. Apotex Health Corp. was founded in 1974 and is headquartered in Toronto, Canada. Apotex Health Corp. operates as a subsidiary of SK Artemis Holdings, II, LLC
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India. The company develops, manufactures, and distributes a broad portfolio of prescription and generic pharmaceuticals, oncology biosimilar pharmaceuticals, branded specialty pharmaceuticals, and branded consumer health and wellness products. It operates through three business lines including conventional generic pharmaceuticals; specialty generic pharmaceuticals; and brands & biosimilars. The company has a a strategic partnership with Halo Pharmaceutical, Inc. The company was formerly known as Artemis Parent, Inc. and changed its name to Apotex Health Corp. in May 2026. Apotex Health Corp. was founded in 1974 and is headquartered in Toronto, Canada. Apotex Health Corp. operates as a subsidiary of SK Artemis Holdings, II, LLC
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free